CD105 expression on CD34-negative spindle-shaped stromal cells of primary tumor is an unfavorable prognostic marker in early breast cancer patients

PLoS One. 2015 Mar 24;10(3):e0121421. doi: 10.1371/journal.pone.0121421. eCollection 2015.

Abstract

Several studies have confirmed that the breast tumor microenvironment drives cancer progression and metastatic development. The aim of our research was to investigate the prognostic significance of the breast tumor microenvironment in untreated early breast cancer patients. Therefore, we analyzed the association of the expression of α-SMA, FSP, CD105 and CD146 in CD34-negative spindle-shaped stromal cells, not associated with the vasculature, in primary breast tumors with classical prognostic marker levels, metastatic recurrence, local relapse, disease-free survival, metastasis-free survival and the overall survival of patients. In the same way, we evaluated the association of the amount of intra-tumor stroma, fibroblasts, collagen deposition, lymphocytic infiltration and myxoid changes in these samples with the clinical-pathological data previously described. This study is the first to demonstrate the high CD105 expression in this stromal cell type as a possible independent marker of unfavorable prognosis in early breast cancer patients. Our study suggests that this new finding can be useful prognostic marker in the clinical-pathological routine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD / metabolism*
  • Antigens, CD34 / metabolism*
  • Biomarkers, Tumor / metabolism*
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology*
  • CD146 Antigen / metabolism
  • Disease-Free Survival
  • Endoglin
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Middle Aged
  • Neoplasm Metastasis
  • Receptors, Cell Surface / metabolism*
  • Recurrence
  • Retrospective Studies
  • Stromal Cells / metabolism
  • Stromal Cells / pathology
  • Tumor Microenvironment

Substances

  • ACTA2 protein, human
  • Actins
  • Antigens, CD
  • Antigens, CD34
  • Biomarkers, Tumor
  • CD146 Antigen
  • ENG protein, human
  • Endoglin
  • Receptors, Cell Surface

Grants and funding

Grant PICT2006 from the National Agency for Science and Technology, Argentina (NAC; http://www.agencia.mincyt.gob.ar/). Grant PIP2011 from the National Council of Scientific and Technical Research (CONICET), Argentina (NAC; http://www.conicet.gov.ar/). Grant 2006–2008, 2009–2011 and 2011–2013 from the Roemmers Foundation, Argentina (NAC; http://www.roemmers.com.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.